An increasing amount of evidence indicates that GLP-1 plays a role in several important age-associated processes, including inflammation, mitochondrial function, and cellular repair
(Regentherapy) In more detail: FOXO4 is a member of the FOXO (Forkhead box O) transcription factor family, which plays major roles in stress response, metabolism, cellular longevity and homeostasis
Home | Healthcare | GLP-1 Receptor Agonist Market Report by Product (Victoza, Ozempic, Trulicity, Bydureon, Saxenda, and Others), Route of Administration (Parenteral, Oral), Application (Type 2 Diabetes Mellitus, Obesity, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics, Online Pharmacies), and Region 2026-2034 Report Format: PDF+Excel | Report ID: SR112026A13049 Report Description Table of Contents Methodology Request Sample GLP-1 Receptor Agonist Market Size: The global GLP-1 receptor agonist market size reached USD 29.0 Billion in 2025
In addition, Ex-4 provides neuroprotection against ischemia-induced damage in the hippocampus by downregulating hypoxia-inducible factor-1 and modulating apoptosis through the increased B-cell lymphoma 2 (Bcl-2)/Bcl-2-associated X-protein (Bax) ratio, which is mediated by the GLP-1 receptor [48]
